High-Speed Analysis of Mycophenolic Acid in Plasma Using Triple Quadrupole LC/MS/MS (LCMS-8050)

Importance of the Topic

Monitoring mycophenolic acid in plasma is essential for therapeutic drug management in organ transplant patients to prevent rejection and minimize adverse effects.

Objectives and Study Overview

This study demonstrates a rapid and sensitive analytical method for quantifying mycophenolic acid in human plasma using a triple quadrupole LC/MS/MS system. A simple deproteinization sample preparation is evaluated for accuracy, precision, and throughput.

Methodology

A one-step deproteinization protocol uses 30 µL plasma mixed with 30 µL of 1 µg/mL isotope-labeled internal standard and 120 µL acetonitrile, followed by vortex, centrifugation, and dilution of the supernatant with water. Calibration standards (0.2–20 µg/mL) and QC samples (0.5, 5, 15 µg/mL) were prepared in plasma.

Used Instrumentation

• Shimadzu LCMS-8050 triple quadrupole mass spectrometer
• Shim-pack GIS column (75×2.1 mm, 3 µm)
• Electrospray ionization in positive mode
• MRM transitions: 321.40 > 207.30 for analyte, 324.40 > 210.30 for internal standard
• Mobile phase: 1% acetic acid in water/ACN (1:1); flow rate 0.3 mL/min; column temperature 40 °C; injection volume 5 µL
• Gas and temperature settings: probe +4.0 kV, DL 150 °C, block heater 200 °C, interface 400 °C; nebulizing 3 L/min, drying 5 L/min, heating 15 L/min

Key Results and Discussion

Linear calibration was achieved from 0.2 to 20 µg/mL with correlation coefficients ≥0.999. Accuracy for calibration standards ranged 94.9–104.7% and repeatability ≤4.38%. QC samples showed accuracy between 103.5–108.5% with repeatability ≤3.66%, confirming method robustness.

Benefits and Practical Applications of the Method

• High throughput analysis with a 4-minute run time
• Minimal and cost-effective sample preparation without solid-phase extraction
• Excellent accuracy and precision suitable for clinical and research laboratories

Future Trends and Possibilities

Integration with automated sample handling and high-resolution mass spectrometry may expand capabilities. Multiplexed assays for immunosuppressants and real-time therapeutic monitoring platforms could enhance patient care.

Conclusion

The described triple quadrupole LC/MS/MS method provides a rapid, reliable, and cost-efficient approach for quantifying mycophenolic acid in plasma, supporting therapeutic drug monitoring in transplant patients.